Connective Tissue Graft Versus a Porcine-derived Membrane (Mucoderm) After Immediate Placement

NCT ID: NCT04737525

Last Updated: 2021-02-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-01

Study Completion Date

2031-02-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Esthetic outcome of immediate implant placement in fresh extraction sockets remains one of the biggest challenges in implant dentistry. Recently a method to preserve the peri-implant tissues was introduced using provisional restoration, allogenic bone and soft tissue thickening. However, the evidence that this immediate provisialisation with soft tissue grafting using different grafting materials results in constantly high Pink Esthetic scores, especially compared to the delayed loading approach is still lacking.

The aim of this clinical trial is to assess the esthetic outcome of immediate temporization of immediately placed and loaded tapered implants in fresh extraction sockets with bone and soft tissue augmentation, using either a connective tissue graft (CTG) or a porcine-derived membrane (Mucoderm) in maxillary anterior sites.

The secondary objectives are to investigate the influence of immediate loading on the success rate of tapered implants and crestal bone levels.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Immediate Implants

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Test group

Immediate implant placement and temporization of tapered implants after tooth extraction with buccal augmentation using allogenic bone and porcine-derived membrane.

Group Type EXPERIMENTAL

Dental implant placement, bone and soft tissue augmentation on buccal site

Intervention Type DEVICE

1. Atraumatic extraction
2. Palatinal positioning of tapered implant (BLX) 3.75mm diameter
3. 3-4 mm below vestibular gingival line or 1 mm below bone crest
4. Implant placement
5. Allogenic bone packing of the "jumping distance" and soft tissue grafting
6. Connective tissue graft (CTG) or porcine-derived membrane
7. Provisional restoration out of occlusion and mandibular movements
8. X-ray

Control group

Immediate implant placement and temporization of tapered implants after tooth extraction with buccal augmentation using allogenic bone and connective tissue grafting (CTG).

Group Type EXPERIMENTAL

Dental implant placement, bone and soft tissue augmentation on buccal site

Intervention Type DEVICE

1. Atraumatic extraction
2. Palatinal positioning of tapered implant (BLX) 3.75mm diameter
3. 3-4 mm below vestibular gingival line or 1 mm below bone crest
4. Implant placement
5. Allogenic bone packing of the "jumping distance" and soft tissue grafting
6. Connective tissue graft (CTG) or porcine-derived membrane
7. Provisional restoration out of occlusion and mandibular movements
8. X-ray

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dental implant placement, bone and soft tissue augmentation on buccal site

1. Atraumatic extraction
2. Palatinal positioning of tapered implant (BLX) 3.75mm diameter
3. 3-4 mm below vestibular gingival line or 1 mm below bone crest
4. Implant placement
5. Allogenic bone packing of the "jumping distance" and soft tissue grafting
6. Connective tissue graft (CTG) or porcine-derived membrane
7. Provisional restoration out of occlusion and mandibular movements
8. X-ray

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Males and females of at least 18 years of age
2. 1 implant per patient
3. Subject must have voluntarily signed the informed consent before any study related action, are willing and able to attend scheduled follow-up visits, and agree that the pseudonymized data will be collected and analyzed
4. Anterior single teeth (canines and incisors) in both jaws
5. Class I extraction socket (intact buccal wall) or Class II (1/3 of buccal wall)
6. No recession of gingival contour of tooth to be extracted
7. No periodontal bone loss of neighboring anterior teeth
8. No implants in neighboring teeth
9. Atraumatic extraction of the tooth with intact socket walls remaining

Exclusion Criteria

1. Deep bite (severe II class)
2. Heavy smokers (more than 10 cigarettes/day)
3. Systemic disease (diabetes, osteoporosis)
4. Primary stability after implant placement not achieved
5. Pregnancy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Straumann Group

UNKNOWN

Sponsor Role collaborator

Vilniaus Implantologijos Centro (VIC) Klinika

NETWORK

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

VIC clinic

Vilnius, , Lithuania

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Lithuania

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IIS1418

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Connective Tissue Graft Versus Collagen Matrix
NCT04210596 ACTIVE_NOT_RECRUITING NA